
XTNT Stock Forecast & Price Target
XTNT Analyst Ratings
Bulls say
Xtant Medical Holdings is a medical technology company that has a clear growth strategy in place to become a leading player in the global orthobiologics market. With a focus on spinal implants and orthobiologics products, along with a network of independent distributors and stocking agents, the company is well positioned to capitalize on the ongoing consolidation in the spine market and the strong demand for its products. Additionally, with a strong capital position and a history of bringing in new assets and achieving profitable growth, Xtant has a solid track record for delivering value to investors.
Bears say
Xtant Medical Holdings is at a disadvantage compared to its peers in the musculoskeletal MedTech industry due to its relatively low revenue and profitability profile, as well as the risks associated with its orthobiologics business. The company is working to improve its capital position by reducing debt and increasing its cash balance, but its recent acquisition of Dilon Technologies may not provide significant revenue growth in the long term. With shares trading at an attractive valuation, there may be limited downside but the company will need to execute well on product launches and increasing distributor interest to drive share prices higher.
This aggregate rating is based on analysts' research of Xtant Medical Holdings and is not a guaranteed prediction by Public.com or investment advice.
XTNT Analyst Forecast & Price Prediction
Start investing in XTNT
Order type
Buy in
Order amount
Est. shares
0 shares